Qualitative Assessment of the Impact of TTNS on QOL and Participation
Launched by MEDSTAR HEALTH RESEARCH INSTITUTE · Jan 28, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how Transcutaneous Tibial Nerve Stimulation (TTNS) affects the everyday lives of people with conditions like neurogenic bladder, urinary retention, and spinal cord injuries. Researchers want to understand participants' experiences after using TTNS for a year, focusing on how it impacts bladder function, any challenges with catheters, and overall quality of life. By conducting interviews and group discussions, they aim to gather insights directly from those who have been part of the TTNS study.
If you are between the ages of 65 and 74 or 27 and 39, and have participated in the TTNS study for at least one year, you may be eligible to join this trial. Participants can expect to share their thoughts and experiences in a supportive environment, helping to shape a better understanding of how TTNS impacts daily living. This information could be essential in improving treatment options for others facing similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion:
- • Participated in TTNS Study for 1 year.
About Medstar Health Research Institute
MedStar Health Research Institute (MHRI) is a leading clinical research organization affiliated with MedStar Health, dedicated to advancing medical knowledge and improving patient care through innovative research initiatives. With a robust portfolio of clinical trials across various therapeutic areas, MHRI collaborates with healthcare professionals, academic institutions, and industry partners to facilitate the development of new treatments and interventions. The institute is committed to maintaining the highest standards of ethical conduct and scientific rigor while fostering a culture of inquiry that enhances the health and well-being of the communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Washington, District Of Columbia, United States
Patients applied
Trial Officials
Emily Leonard, PhD
Principal Investigator
Medstar Health Research Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials